Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1984 3
1986 1
1991 5
1992 4
1993 3
1994 3
1995 3
1996 3
1997 3
1998 4
1999 9
2000 7
2001 7
2002 5
2003 12
2004 23
2005 23
2006 22
2007 33
2008 39
2009 44
2010 54
2011 82
2012 75
2013 94
2014 110
2015 129
2016 156
2017 172
2018 173
2019 216
2020 246
2021 93
Text availability
Article attribute
Article type
Publication date

Search Results

1,707 results
Results by year
Filters applied: . Clear all
Page 1
Standards of medical care for type 2 diabetes in China 2019.
Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z, Zou D, Guo L, Ji Q, Chen L, Chen L, Dou J, Guo X, Kuang H, Li L, Li Q, Li X, Liu J, Ran X, Shi L, Song G, Xiao X, Yang L, Zhao Z; Chinese Diabetes Society. Jia W, et al. Among authors: zou d. Diabetes Metab Res Rev. 2019 Sep;35(6):e3158. doi: 10.1002/dmrr.3158. Epub 2019 May 29. Diabetes Metab Res Rev. 2019. PMID: 30908791 Review.
Circular RNA CDR1as disrupts the p53/MDM2 complex to inhibit Gliomagenesis.
Lou J, Hao Y, Lin K, Lyu Y, Chen M, Wang H, Zou D, Jiang X, Wang R, Jin D, Lam EW, Shao S, Liu Q, Yan J, Wang X, Chen P, Zhang B, Jin B. Lou J, et al. Among authors: zou d. Mol Cancer. 2020 Sep 7;19(1):138. doi: 10.1186/s12943-020-01253-y. Mol Cancer. 2020. PMID: 32894144 Free PMC article.
The role of klotho in chronic kidney disease.
Zou D, Wu W, He Y, Ma S, Gao J. Zou D, et al. BMC Nephrol. 2018 Oct 22;19(1):285. doi: 10.1186/s12882-018-1094-z. BMC Nephrol. 2018. PMID: 30348110 Free PMC article. Review.
Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study.
Song Y, Gao Q, Zhang H, Fan L, Zhou J, Zou D, Li W, Yang H, Liu T, Wang Q, Lv F, Guo H, Yang L, Elstrom R, Huang J, Novotny W, Wei V, Zhu J. Song Y, et al. Among authors: zou d. Leukemia. 2020 Feb;34(2):533-542. doi: 10.1038/s41375-019-0545-2. Epub 2019 Sep 13. Leukemia. 2020. PMID: 31520078 Free PMC article. Clinical Trial.
Treatment of Patients with Relapsed or Refractory Mantle-Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase.
Song Y, Zhou K, Zou D, Zhou J, Hu J, Yang H, Zhang H, Ji J, Xu W, Jin J, Lv F, Feng R, Gao S, Guo H, Zhou L, Elstrom R, Huang J, Novotny W, Wei R, Zhu J. Song Y, et al. Among authors: zou d. Clin Cancer Res. 2020 Aug 15;26(16):4216-4224. doi: 10.1158/1078-0432.CCR-19-3703. Epub 2020 May 27. Clin Cancer Res. 2020. PMID: 32461234 Free article.
1,707 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page